Visit-to-visit lipid variability, coronary artery calcification, inflammation, and mortality in the Multi-Ethnic

Jeffrey Shi Kai Chan1,2, Danish Iltaf Satti3, Raymond Ngai Chiu Chan1,4

  • 1Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong SAR, China.

Insights

High variability in high-density lipoprotein cholesterol (HDL-C) is linked to increased coronary artery calcification (CAC) and higher risks of cardiovascular and all-cause mortality. This association may extend beyond atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • Visit-to-visit variability in lipid levels, such as high-density lipoprotein cholesterol (HDL-C), is an emerging area of research.
  • Understanding the prognostic relevance of lipid variability is crucial for cardiovascular risk assessment.

Purpose of the Study:

  • To investigate the association between visit-to-visit lipid variability (HDL-C, LDL-C, TC, triglycerides) and coronary artery calcification (CAC).
  • To explore the relationship between lipid variability and long-term risks of cardiovascular mortality, all-cause mortality, and inflammation (hsCRP).

Main Methods:

  • Prospective cohort study utilizing data from the Multi-Ethnic Study of Atherosclerosis.
  • Calculated visit-to-visit variability (coefficient of variation) for lipids from three initial exams.
  • Assessed CAC using computed tomography and tracked mortality outcomes over a median follow-up of 15.1 years.

Main Results:

  • Higher HDL-C variability correlated with greater CAC burden (Agatston score).
  • Increased HDL-C and TC variability were associated with higher cardiovascular mortality risk, independent of CAC.
  • HDL-C variability also predicted higher all-cause mortality risk and correlated with hsCRP levels.

Conclusions:

  • Elevated HDL-C variability is a significant predictor of increased CAC and long-term mortality.
  • The observed mortality associations suggest mechanisms potentially beyond established atherosclerosis.
  • Lipid variability, particularly in HDL-C, warrants consideration in cardiovascular risk stratification.
Abstract